Back to Search
JOSEPH DIPERSIO, PH.D.
PH.D.
Microbiology Specialist/Technologist
NPI: 1376628826Individual
Specialties, Licenses & Credentials
Microbiology Specialist/TechnologistPrimary
Specialist/Technologist, Pathology — Microbiology
Code: 246QM0900X
Research & Publications (20)
Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial.
PMID 17376657·Int J Antimicrob Agents·2007
4-observational
Evolution and dissemination of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: epidemiology and molecular report from the SENTRY Antimicrobial Surveillance Program (1997-2003).
PMID 15629222·Diagn Microbiol Infect Dis·2005
8-other
Acquired copy number alterations in adult acute myeloid leukemia genomes.
PMID 19651600·Proc Natl Acad Sci U S A·2009
8-other
Advances in mobilization for the optimization of autologous stem cell transplantation.
PMID 19603345·Leuk Lymphoma·2009
6-review
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.
PMID 19050309·Blood·2009
7-preclinical
A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes.
PMID 19650118·Am J Hematol·2009
3-trial
BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells.
PMID 19571319·Blood·2009
7-preclinical
Recurring mutations found by sequencing an acute myeloid leukemia genome.
PMID 19657110·N Engl J Med·2009
5-case
Allo-SCT conditioning for myelodysplastic syndrome and acute myeloid leukemia with clofarabine, cytarabine and ATG.
PMID 19139740·Bone Marrow Transplant·2009
3-trial
Improving stem cell mobilization strategies: future directions.
PMID 19139734·Bone Marrow Transplant·2009
6-review
Management of the advanced phases of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors.
PMID 19117213·Leuk Lymphoma·2009
6-review
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.
PMID 19363221·Blood·2009
3-trial
Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study.
PMID 19029964·Bone Marrow Transplant·2009
3-trial
Early outcomes after allogeneic hematopoietic SCT in pediatric patients with hematologic malignancies following single fraction TBI.
PMID 19011666·Bone Marrow Transplant·2009
8-other
Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up.
PMID 19369231·Blood·2009
3-trial
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome.
PMID 18987736·Nature·2008
8-other
A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma.
PMID 18940680·Biol Blood Marrow Transplant·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 525 E MARKET ST, SUMMA HEALTH SYSTEM, DEPT OF PATHOLOGY
AKRON, OH 44304 - Phone
- (330) 375-3667
Quick Facts
- NPI
- 1376628826
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile